Rite Aid Reports Net Income of $21.5 Million and Adjusted EBITDA of $346.8 Million for Second Quarter Fiscal 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. ROIV
7. ORCL
8. TTAN
9. NVS
10. INTC

Go back to Rite Aid Reports Net Income of $21.5 Million and Adjusted EBITDA of $346.8 Million for Second Quarter Fiscal 2016

Mizuho Securities Reiterates Buy on Rite Aid (RAD) Following 2Q16

September 17, 2015 2:29 PM EDT

Mizuho Securities reiterated a Buy rating and $10.00 price target on Rite-Aid (NYSE: RAD) following the company's 2Q16 earnings results. RAD reported adjusted EBITDA of $346.8mm was modestly above consensus of $344.2mm.

Analyst Ann Hynes commented, "We would be buyers of RAD on earnings-related... More

Cowen Remains Bullish on Rite Aid (RAD) Following 2c EPS Miss

September 17, 2015 1:13 PM EDT

Cowen reiterated an Outperform rating and $12.00 price target on Rite-Aid (NYSE: RAD) following the company's 2Q16 earnings. RAD reported EPS of $0.02, which missed consensus of $0.04. Rev of $7.66B, consisting of $6.65B from retail pharmacy and $1.07B from pharmacy services, came in ahead of... More

Rite Aid (RAD) Misses Q2 EPS by 2c; Trims FY16 EPS Outlook

September 17, 2015 7:02 AM EDT

Rite Aid (NYSE: RAD) reported Q2 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.57 billion.

Same store drugstore sales for the Retail Pharmacy Segment increased 2.1 percent over the prior year,... More